Core2 1-6-N-Glucosaminyltransferase-I Deficiency Protects Injured Arteries From Neointima Formation in ApoE-Deficient Mice
Author(s) -
Huan Wang,
Weiyu Zhang,
Rong Tang,
Robert P. Hebbel,
M. Anna Kowalska,
Chunxiang Zhang,
Jamey D. Marth,
Minoru Fukuda,
Chuhong Zhu,
Yuqing Huo
Publication year - 2009
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.109.187716
Subject(s) - neointima , apolipoprotein e , restenosis , medicine , platelet , regeneration (biology) , endothelial dysfunction , pathology , endocrinology , microbiology and biotechnology , biology , stent , disease
Core2 1 to 6-N-glucosaminyltransferase-I (C2GlcNAcT-I) plays an important role in optimizing the binding functions of several selectin ligands, including P-selectin glycoprotein ligand. We used apolipoprotein E (ApoE)-deficient atherosclerotic mice to investigate the role of C2GlcNAcT-I in platelet and leukocyte interactions with injured arterial walls, in endothelial regeneration at injured sites, and in the formation of arterial neointima.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom